HTBX - Heat Biologics Inc
Close
2.38
0.010 0.420%
Share volume: 43,610
Last Updated: Mon 02 May 2022 10:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$2.37
0.01
0.42%
Summary score
29%
Profitability
27%
Dept financing
10%
Liquidity
33%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-26.32%
Return on assets
-17.38%
Return on sales
0%
Return on invested capital
13.11%
Total debt ratio
33.69%
Debt ratio change over timeo
-1.41%
Current Ratio
3.91%
Quick Ratio
0%
Cash Position Ratio
3%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-23.61%
Return on assets
-11.99%
Return on sales
0%
Return on invested capital
-110.36%
Total debt ratio
38.31%
Debt ratio change over timeo
-1.87%
Current Ratio
4.17%
Quick Ratio
0%
Cash Position Ratio
2.33%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-9.34%
Return on assets
-6.88%
Return on sales
0%
Return on invested capital
-102.78%
Total debt ratio
17.95%
Debt ratio change over time
-1.11%
Current Ratio
7.66%
Quick Ratio
0%
Cash Position Ratio
3.32%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-73.54%
Return on assets
-85.94%
Return on sales
0%
Return on invested capital
100.98%
Total debt ratio
-140.89%
Debt ratio change over time
-1.41%
Current Ratio
-5.59%
Quick Ratio
0%
Cash Position Ratio
-4.36%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | HTBX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -26.32% | 0% | 0% | 29.06% |
| Return on assets | -17.38% | 0% | 0% | -9.75% |
| Return on sales | 0% | 0% | 0% | -1469.44% |
| Return on invested capital | 13.11% | 0% | 0% | 47.78% |
| Profitability | 32% | 0% | 25% | 50% |
| Total debt ratio | 33.69% | 0% | 0% | 183.15% |
| Debt ratio change over time | -1.41% | 0% | 0% | 19.02% |
| Dept financing | 5% | 0% | 0% | 50% |
| Current Ratio | 4.17% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.33% | 0% | 0% | 5.68% |
| Liquididy | 44% | 0% | 0% | 75% |
| Short-term ratios | HTBX | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -23.61% | 0% | 0% | -16.12% |
| Return on assets | -11.99% | 0% | 0% | -14.95% |
| Return on sales | 0% | 0% | 0% | -3498.94% |
| Return on invested capital | -110.36% | 0% | 0% | 96.56% |
| Profitability | 25% | 0% | 50% | 25% |
| Total debt ratio | 38.31% | 0% | 0% | 79.61% |
| Debt ratio change over time | -1.87% | 0% | 0% | 0.09% |
| Dept financing | 12% | 0% | 0% | 50% |
| Current Ratio | 4.17% | 0% | 0% | 5.9% |
| Quick Ratio | 0% | 0% | 0% | 5.9% |
| Cash Position Ratio | 2.33% | 0% | 0% | 5.68% |
| Liquididy | 28% | 0% | 0% | 75% |